Nora Brennan - 03 Jan 2023 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role
Executive Vice President and Chief Financial Officer
Signature
/s/ Keith M. McGahan, Attorney-in-Fact for Nora E. Brennan
Issuer symbol
N/A
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 18:49:14 UTC
Previous filing
23 Jun 2022
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +240,000 +67% $0.000000 600,215 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +840,000 $0.000000 840,000 03 Jan 2023 Common Stock 840,000 $0.3800 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
F2 One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.

Remarks:

Executive Vice President and Chief Financial Officer